Cardiovascular Care for an Ageing Population
Cardiovascular diseases are the leading cause of death and hospitalisation worldwide, with the west of Scotland facing some of the highest rates. As populations age, advancing prevention, diagnosis and treatment is more critical than ever.
Our researchers are tackling heart failure, stroke and dementia. Stroke, a major cause of disability and mortality, is projected to more than double between 2010 and 2050, with the greatest impact on older adults and minority groups.
Glasgow has a distinguished history in geriatric care, establishing the world’s first Chair in Clinical Geriatrics in 1965. Now, thanks to a transformative gift from the DWT Cargill Fund, the prestigious David Cargill Chair of Geriatric Medicine has been re-established, held by Professor Terry Quinn. This funding also enabled the appointment of an additional Clinical Senior Lecturer, growing the research team and amplifying impact.
“Our work in understanding and treating cardiovascular disease in an ageing population is built on four key pillars: policy, advocacy, people and research.” “Ageing is universal, and older people are not ‘other’; advocacy and person-centred care must be at the heart of our approach," explains Professor Quinn. "This philosophy ensures inclusivity and refines how we develop treatments and interventions.”
Professor Quinn emphasises the need to invest in people: “Our researchers are our greatest asset. By supporting and retaining talented individuals, we can continue advancing knowledge and improving care for older adults.”
Professor Godfrey Smith, Director of Innovation, Engagement & Enterprise, highlights philanthropy’s role in driving progress: “Philanthropic funds provide the flexibility we need to innovate. The DWT Cargill Fund’s generosity demonstrates the ripple effect of philanthropy – allowing us to reinvest, grow our research capacity and attract further funding to push the boundaries of cardiovascular and geriatric medicine.”
Thanks to You
With donor support, the University continues to lead in improving health outcomes for older adults, ensuring research translates into life-changing impact.
In 2026, the BHF Glasgow Cardiovascular Research Centre will mark 20 years of pioneering research. As part of this milestone, Giving to Glasgow 2026 will explore the past, present and future of cardiovascular breakthroughs at Glasgow.
Thanks to You
With donor support, the University continues to lead in improving health outcomes for older adults, ensuring research translates into life-changing impact.
